Scientific Highlights from Research Division
Biology and Chemistry (BIO)
Bench-to-bedside successes: Fruitful collaborations at PSI’s Center for Radiopharmaceutical Sciences make bringing Terbium-161 to the clinic a reality.
A dream drug would provide a targeted therapeutic effect without side effects. Biased signalling could make this a reality. Publishing in PNAS, PSI researchers present a platform for biased signalling-based drug discovery.
In an interdisciplinary project, researchers from the Laboratory of Nanoscale Biology in BIO and the Laboratory for Condensed Matter in PSD have revealed the reaction between the nitrogen atoms of the amyloid-beta peptide and copper/zinc ions by using soft X-ray absorption spectroscopy.
Viviane Tschan received this year’s Marie-Curie Award for a new concept of radioligand therapy of prostate cancer.
PSI researchers have developed a new method to attach proteins to the surface of virus-like particles.
PSI is engaging in public outreach at a major event in Zürich, the "Scientifica" Science Days September 4 and 5.
Prof. Dr. Roger Schibli has been elected a Council Member 2020-2022 of the European Society for Molecular Imaging - ESMI
European Society for Molecular Imaging - ESMI
The ESMI represents and advocates IMAGING SCIENCE
The ESMI is providing an international, interdisciplinary platform for knowledge exchange in the field covering basic sciences, translational aspects as well as clinical applications.
Single-particle cryo-electron microscopy of a functional Aβ42 pore equivalent, created by fusing Aβ42 to the oligomerizing, soluble domain of the α-hemolysin toxin, offers new insights into structure and function of proteins forming amyloid aggregates in Alzheimer’s disease.